ACM

Asymmetry Capital Management Portfolio holdings

AUM $188M
This Quarter Return
+9.67%
1 Year Return
+45.88%
3 Year Return
+300.28%
5 Year Return
+633.15%
10 Year Return
AUM
$193M
AUM Growth
+$193M
Cap. Flow
-$21.3M
Cap. Flow %
-11%
Top 10 Hldgs %
57.01%
Holding
46
New
13
Increased
3
Reduced
13
Closed
17

Sector Composition

1 Healthcare 99.55%
2 Financials 0.45%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
FBRX icon
26
Forte Biosciences
FBRX
$137M
$1.82M 0.94% 53,197 -31,792 -37% -$1.09M
TPTX
27
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$1.12M 0.58% +11,873 New +$1.12M
BLSA
28
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$871K 0.45% 82,377 -6,758 -8% -$71.5K
GLTO icon
29
Galecto
GLTO
$4.21M
$690K 0.36% 113,515 -223,837 -66% -$1.36M
BMRN icon
30
BioMarin Pharmaceuticals
BMRN
$11.2B
-88,195 Closed -$7.73M
BNR
31
Burning Rock Biotech
BNR
$93.6M
-217,728 Closed -$5.03M
CCCC icon
32
C4 Therapeutics
CCCC
$185M
-139,343 Closed -$4.62M
CDXS icon
33
Codexis
CDXS
$246M
-318,492 Closed -$6.95M
ELDN icon
34
Eledon Pharmaceuticals
ELDN
$155M
-80,069 Closed -$1.23M
FATE icon
35
Fate Therapeutics
FATE
$120M
-50,709 Closed -$4.61M
KALV icon
36
KalVista Pharmaceuticals
KALV
$678M
-46,910 Closed -$891K
LAB icon
37
Standard BioTools
LAB
$481M
-1,544,904 Closed -$9.27M
NCNA
38
NuCana
NCNA
$6.09M
-613,769 Closed -$2.76M
ORIC icon
39
Oric Pharmaceuticals
ORIC
$994M
-67,210 Closed -$2.28M
STRO icon
40
Sutro Biopharma
STRO
$72.7M
-157,583 Closed -$3.42M
TXG icon
41
10x Genomics
TXG
$1.74B
-37,587 Closed -$5.32M
VTGN icon
42
VistaGen Therapeutics
VTGN
$102M
-2,239,803 Closed -$4.35M
VTRS icon
43
Viatris
VTRS
$12.3B
-1,130,504 Closed -$21.2M
WVE icon
44
Wave Life Sciences
WVE
$1.53B
-280,924 Closed -$2.21M
ITCI
45
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-130,654 Closed -$4.16M
BMY.RT
46
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
-5,152,098 Closed -$3.55M